Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimiliano Pacilio

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|March 23, 2022
Yttrium-90 Radioembolization of Colorectal Cancer Liver Metastases: A Systematic Review of Clinical EvidenceEdoardo d'Andrea, Mariarita Russi, Massimiliano Pacilio, et al.
Nuclear Medicine Communications|June 9, 2005
Management of 131I therapy for thyroid cancer: cumulative dose from in-patients, discharge planning and personnel requirementsMassimiliano Pacilio, Luciano Bianciardi, Vincenzo Panichelli, et al.
Medical Physics|November 7, 2012
An analytical method for computing voxel S values for electrons and photonsErnesto Amato, Fabio Minutoli, Massimiliano Pacilio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2013
Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMPMassimiliano Pacilio, Guido Ventroni, Chiara Basile, et al.
Diagnostics (Basel, Switzerland)|March 3, 2018
Dosimetry-Based Consideration on Remission and Relapse after Therapy with <sup>223</sup>Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case ReportAnna Maria Mangano, Massimiliano Pacilio, Pasquale Ialongo, et al.
Annals of Nuclear Medicine|December 30, 2017
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with <sup>223</sup>Radium-dichlorideViviana Frantellizzi, Alessio Farcomeni, Giulia Anna Follacchio, et al.
Physics in Medicine and Biology|January 10, 2019
T1 and extracellular volume fraction mapping in cardiac magnetic resonance: estimation of accuracy and precision of a novel algorithmCristian Borrazzo, Massimiliano Pacilio, Nicola Galea, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 14, 2010
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with (90)Y-ibritumomab tiuxetan (Zevalin)Massimiliano Pacilio, Margherita Betti, Francesco Cicone, et al.
Annals of Nuclear Medicine|November 29, 2015
A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-upMassimiliano Pacilio, Guido Ventroni, Bartolomeo Cassano, et al.
Current Radiopharmaceuticals|July 29, 2020
Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's DiseaseViviana Frantellizzi, Valentina Lavelli, Cristina Ferrari, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|March 23, 2022
Yttrium-90 Radioembolization of Colorectal Cancer Liver Metastases: A Systematic Review of Clinical EvidenceEdoardo d'Andrea, Mariarita Russi, Massimiliano Pacilio, et al.
Nuclear Medicine Communications|June 9, 2005
Management of 131I therapy for thyroid cancer: cumulative dose from in-patients, discharge planning and personnel requirementsMassimiliano Pacilio, Luciano Bianciardi, Vincenzo Panichelli, et al.
Medical Physics|November 7, 2012
An analytical method for computing voxel S values for electrons and photonsErnesto Amato, Fabio Minutoli, Massimiliano Pacilio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2013
Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMPMassimiliano Pacilio, Guido Ventroni, Chiara Basile, et al.
Diagnostics (Basel, Switzerland)|March 3, 2018
Dosimetry-Based Consideration on Remission and Relapse after Therapy with <sup>223</sup>Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case ReportAnna Maria Mangano, Massimiliano Pacilio, Pasquale Ialongo, et al.
Annals of Nuclear Medicine|December 30, 2017
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with <sup>223</sup>Radium-dichlorideViviana Frantellizzi, Alessio Farcomeni, Giulia Anna Follacchio, et al.
Physics in Medicine and Biology|January 10, 2019
T1 and extracellular volume fraction mapping in cardiac magnetic resonance: estimation of accuracy and precision of a novel algorithmCristian Borrazzo, Massimiliano Pacilio, Nicola Galea, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 14, 2010
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with (90)Y-ibritumomab tiuxetan (Zevalin)Massimiliano Pacilio, Margherita Betti, Francesco Cicone, et al.
Annals of Nuclear Medicine|November 29, 2015
A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-upMassimiliano Pacilio, Guido Ventroni, Bartolomeo Cassano, et al.
Current Radiopharmaceuticals|July 29, 2020
Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's DiseaseViviana Frantellizzi, Valentina Lavelli, Cristina Ferrari, et al.
Pageof 3